BioMarin Announces Second Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to BioMarin Announces Second Quarter 2017 Financial Results

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $119 at Deutsche Bank

August 3, 2017 8:52 AM EDT

Deutsche Bank raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $119.00 (from $118.00) while maintaining a Buy rating.

Analyst Andrew Peters commented, "Todays results and hemophilia update continue to support our bullish view on BioMarins diversified and high-growth portfolio. Second quarter... More

BioMarin Pharma (BMRN) Reports In-Line Q2 EPS

August 2, 2017 4:27 PM EDT

BioMarin Pharma (NASDAQ: BMRN) reported Q2 GAAP EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $317.4 million versus the consensus estimate of $308.96 million.

For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.

... More